ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Coronary Computed Tomography Angiography for Pre-Liver Transplant Cardiovascular Risk Assessment: A Single Center Experience

J. Rice1, T. Genders2, D. Groves2, J. R. Burton1, J. Moloo2, R. Quaife2, D. Vargas3, M. Kriss1

1Division of Gastroenterology and Hepatology, University of Colorado, Aurora, CO, 2Division of Cardiology, University of Colorado, Aurora, CO, 3Division of Radiology, University of Colorado, Aurora, CO

Meeting: 2021 American Transplant Congress

Abstract number: 244

Keywords: Angiography, Liver, Screening, Vascular disease

Topic: Clinical Science » Liver » Liver: Recipient Selection

Session Information

Session Name: Liver Recipient Selection

Session Type: Rapid Fire Oral Abstract

Date: Monday, June 7, 2021

Session Time: 4:30pm-5:30pm

 Presentation Time: 4:45pm-4:50pm

Location: Virtual

*Purpose: Coronary computed tomography angiography (CCTA) is an established non-invasive imaging modality for diagnosing coronary artery disease (CAD), though its use for cardiovascular disease (CVD) risk assessment prior to liver transplant (LT) remains limited. Our center has incorporated routine CCTA into our pre-LT CVD risk assessment protocol and the purpose of this study is to examine the efficacy and safety of the protocol.

*Methods: We retrospectively reviewed all patients undergoing LT evaluation at our center from 7/1/18 to 6/30/20. Patients evaluated for acute liver failure or re-transplant were excluded. Coronary artery calcium (CAC) scores, CAD reporting and data system (CAD-RADS) scores, medication administration, and adverse outcomes were collected on all patients. Patients with pre-existing CAD underwent invasive coronary angiography (ICA). Patients age >50 or age 40-50 with longstanding diabetes or >10 pack-year smoking history underwent CCTA if GFR >40 cc/min. Patients with contraindications to CCTA underwent stress echocardiogram or ICA based on CVD risk factors. CAD was defined as the presence of any atherosclerotic coronary disease. All patients with obstructive CAD, defined as any vessel >70% stenosis (or left main >50%) or lesions with positive (< 0.8) fractional flow reserve computed tomography (FFR-CT), underwent ICA.

*Results: A total of 605 patients were evaluated for LT with 278 completing CCTA, however 8 completed only CAC score due to high calcium burden. CCTA results are shown in Table 1. CAD was diagnosed in 63.8% of patients, of whom 8.5% had obstructive CAD. Median CAC scores were higher for obstructive CAD versus nonobstructive (537 [IQR 123-1300] vs 74 [IQR 13-263], p=0.019). FFR-CT was performed in 32 patients with 46.9% having a flow limiting lesion. Metoprolol was administered in 69.2% of patients to achieve adequate heart rate (<70 bpm) and nitroglycerine in 69.2% to achieve coronary hyperemia. Only 2 patient required escalation of care for hypotension. A total of 42 patients (15.2%) required ICA after CCTA.

*Conclusions: CCTA is a promising non-invasive imaging modality for detecting CAD during pre-liver transplant CVD risk assessment with a high technical success rate and low complication rates.

Table 1: CCTA Results
CAD-RADS Score N (%)
0 (No plaque or stenosis) 56 (20.7%)
1 (1-24% stenosis) 80 (29.6%)
2 (25-49% stenosis) 58 (21.5%)
3 (50-69% stenosis) 23 (8.5%)
4 (70-99% stenosis or >50% left main stenosis) 14 (5.2%)
5 (100% occlusion) 1 (0.4%)
N (Non-diagnostic) 38 (14.1%)
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Rice J, Genders T, Groves D, Burton JR, Moloo J, Quaife R, Vargas D, Kriss M. Coronary Computed Tomography Angiography for Pre-Liver Transplant Cardiovascular Risk Assessment: A Single Center Experience [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/coronary-computed-tomography-angiography-for-pre-liver-transplant-cardiovascular-risk-assessment-a-single-center-experience/. Accessed May 30, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences